logo

Clinical Trial Calendar

Share SHARE
Results Date
Company Name
Ticker
Event
Indication
Outcome
Details
Mar 2017
22nd Century Group Inc.
Completion of phase 3 study of SPECTRUM tobacco
harm caused by smoking
Mid Feb 2017
Biota Pharmaceuticals Inc.
Topline data from phase 2b trial of Vapendavir (SPIRITUS)
Adult asthmatics with symptomatic human rhinovirus
Q1 2017
Ardelyx, Inc
Results from 1st phase 3 trial of Tenapanor
Hyperphosphatemia in ESRD patients
Q1 2017
Alcobra Ltd.
Data from 2nd phase 3 study of Metadoxine Extended Release (MEASURE)
Adults with ADHD
Early 2017
Karyopharm Therapeutics Inc.
Top-line data from Phase 2b study of Selinexor (SADAL study)
Relapsed/refractory diffuse large B-cell lymphoma (DLBCL)
Q1 2017
GW Pharmaceuticals PLC
GWPH, GWP.L
Data from phase 2 study of CBDV
Partial-onset epilepsy
Q1 2017
Nivalis Therapeutics, Inc.
Data from 2nd phase 2 trial of Cavosonstat (N91115)
Cystic fibrosis
2017
MERRIMACK PHARMACEUTICALS, INC.
Results from phase 2 study of ONIVYDE
Previously untreated front-line metastatic pancreatic cancer
2017
MERRIMACK PHARMACEUTICALS, INC.
Results from phase 2 study of MM-302 (HERMIONE)
HER2-positive metastatic breast cancer
2017
Exelixis, Inc.
Topline results from phase 3 trial of Cometriq (CELESTIAL)
Patients with advanced HCC who have previously been treated with sorafenib
1H 2017
Allergan Inc.
Topline results from Phase III trials of ulipristal acetate (Venus II)
Treatment of Uterine Fibroids
Q1 2017
AEterna Zentaris Inc
AEZ.TO, AEZS
Topline results from phase 3 trial of Zoptrex
Endometrial cancer
Early 2017
AEterna Zentaris Inc
AEZ.TO, AEZS
Topline results from phase 3 trial of Macrilen
Adult Growth Hormone Deficiency
2017
Tracon Pharmaceuticals, Inc.
Topline results from phase 1/2 trial of TRC105
Breast cancer
Early 2017
FibroGen Inc.
Data from phase 3 studies of Roxadustat
Anemia in Chronic Kidney Disease
1H 2017
BioTime Inc
Topline data from pivotal trial of Renevia
Restoring normal skin contours in patients whose adipose tissue has been lost due to antiviral drug treatment for HIV
1H 2017
Dipexium Pharmaceuticals Inc.
To submit NDA for Locilex
Treatment of patients with mild infections of diabetic foot ulcers
1H 2017
Dipexium Pharmaceuticals Inc.
To submit MAA for Locilex
Treatment of patients with mild infections of diabetic foot ulcers
Q1 2017
EYEGATE PHARMACEUTICALS INC
Topline data from confirmatory Phase 3 trial of EGP-437 combination product
Non-infectious anterior uveitis;
Jan 2017
Summit Therapeutics plc
Initial data from phase 2 trial of Ezutromid (PhaseOut DMD)
Duchenne muscular dystrophy
Q1 2017
Trevena, Inc.
Topline data from phase 3 study of Oliceridine (APOLLO-1)
Acute pain
Q1 2017
Trevena, Inc.
Topline data from phase 3 study of Oliceridine (APOLLO-2)
Acute pain
2017
Corcept Therapeutics Inc
Initial results from Phase 1/2 Trial of CORT125134
To Treat Solid-Tumor Cancers
1H 2017
Opiant Pharmaceuticals Inc.
OPNT.OB
Top-line results from phase 2 study of opioid antagonists
Patients with cocaine use disorder.
Q1 2017
Zosano Pharma Corporation
Data from pivotal efficacy trial of M207 (formerly ZP-Triptan patch )
Acute migraine